Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture.
Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

NATEGLINIDE IMPURITY B CRS (15 MG)

NATEGLINIDE IMPURITY B CRS (15 MG)

NA

DISCOVER
NATEGLINIDE IMPURITY C CRS (10 MG)

NATEGLINIDE IMPURITY C CRS (10 MG)

NA

DISCOVER
BICALUTAMIDE CRS (160 MG)

BICALUTAMIDE CRS (160 MG)

90357-06-5

DISCOVER
CELECOXIB CRS (160 MG)

CELECOXIB CRS (160 MG)

169590-42-5

DISCOVER
CELECOXIB IMPURITY A CRS (10 MG)

CELECOXIB IMPURITY A CRS (10 MG)

NA

DISCOVER
CELECOXIB IMPURITY B CRS (10 MG)

CELECOXIB IMPURITY B CRS (10 MG)

NA

DISCOVER
BICALUTAMIDE FOR SYSTEM SUITABILITY CRS (10 MG)

BICALUTAMIDE FOR SYSTEM SUITABILITY CRS (10 MG)

90357-06-5

DISCOVER
CHLORPROMAZINE IMPURITY F CRS(2 MG)

CHLORPROMAZINE IMPURITY F CRS(2 MG)

NA

DISCOVER
CAPTOPRIL IMPURITY J CRS (10 MG)

CAPTOPRIL IMPURITY J CRS (10 MG)

64838-55-7

DISCOVER
CHLORTETRACYCLINE FOR SYSTEM SUITABILITY CRS (10 MG)

CHLORTETRACYCLINE FOR SYSTEM SUITABILITY CRS (10 MG)

64-72-2

DISCOVER
DOCETAXEL IMPURITY E CRS (15 MG)

DOCETAXEL IMPURITY E CRS (15 MG)

32981-86-5

DISCOVER
DULOXETINE HYDROCHLORIDE CRS (120 MG)

DULOXETINE HYDROCHLORIDE CRS (120 MG)

136434-34-9

DISCOVER